Literature DB >> 20579741

Second-tier natural antidepressants: review and critique.

Nadia Iovieno1, Elizabeth D Dalton, Maurizio Fava, David Mischoulon.   

Abstract

The use of Complementary and Alternative Medicine (CAM) for physical and mental problems has increased significantly in the US over the past two decades, and depression is one of the leading indications for the use of CAM. This article reviews some of the lesser-known natural products with potential psychiatric applications that are starting to emerge with some scientific and clinical evidence and may constitute a next wave of natural antidepressants: Rhodiola rosea, chromium, 5-Hydroxytryptophan (5-HTP) and inositol. Background information, efficacy data, proposed mechanisms of action, recommended doses, side effects, and precautions are reviewed. We found some encouraging data for the use of these natural products in specific populations of depressed patients. R. rosea is an adaptogen plant that can be especially helpful in treating asthenic or lethargic depression, and may be combined with conventional antidepressants to alleviate some of their common side effects. Chromium has a beneficial effect on eating-related atypical symptoms of depression, and may be a valuable agent in treating atypical depression and seasonal affective disorder. Inositol may be useful in the treatment of bipolar depression when combined with mood stabilizers. Evidence for the clinical efficacy of 5-HTP is also promising but still preliminary. Although more well-designed and larger controlled studies are needed before any substantive conclusions can be drawn, the available evidence is compelling and these natural products deserve further investigation as a possibly significant addition to the antidepressant armamentarium.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579741     DOI: 10.1016/j.jad.2010.06.010

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  11 in total

Review 1.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.

Authors:  Arun V Ravindran; Lynda G Balneaves; Guy Faulkner; Abigail Ortiz; Diane McIntosh; Rachel L Morehouse; Lakshmi Ravindran; Lakshmi N Yatham; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

2.  Phytases Improve Myo-Inositol Bioaccessibility in Rye Bread: A Study Using an In Vitro Method of Digestion and a Caco-2 Cell Culture Model.

Authors:  Robert Duliński; Emilia Katarzyna Cielecka; Małgorzata Pierzchalska; Krzysztof Żyła
Journal:  Food Technol Biotechnol       Date:  2015-03       Impact factor: 3.918

3.  Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder.

Authors:  Hitoshi Sakurai; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price; George I Papakostas; Christina M Dording; Albert S Yeung; Cristina Cusin; Elizabeth Ludington; Richard Bernard-Negron; Maurizio Fava; David Mischoulon
Journal:  J Affect Disord       Date:  2019-10-31       Impact factor: 4.839

4.  Total Saikosaponins Attenuates Depression-Like Behaviors Induced by Chronic Unpredictable Mild Stress in Rats by Regulating the PI3K/AKT/NF-κB Signaling Axis.

Authors:  Zhicong Zhou; Hui Chen; Xiaoyan Tang; Binghong He; Lingxia Gu; Huancun Feng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-18       Impact factor: 2.650

Review 5.  Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.

Authors:  Jacob P R Jacobsen; Andrew D Krystal; K Ranga R Krishnan; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2016-09-28       Impact factor: 14.819

6.  Antidepressant-like effects and memory enhancement of a herbal formula in mice exposed to chronic mild stress.

Authors:  Xiu-Ping Sun; Si-Di Li; Zhe Shi; Teng-Fei Li; Rui-Le Pan; Qi Chang; Chuan Qin; Xin-Min Liu
Journal:  Neurosci Bull       Date:  2013-10-16       Impact factor: 5.203

7.  Synergy and Antagonism of Active Constituents of ADAPT-232 on Transcriptional Level of Metabolic Regulation of Isolated Neuroglial Cells.

Authors:  Alexander Panossian; Rebecca Hamm; Onat Kadioglu; Georg Wikman; Thomas Efferth
Journal:  Front Neurosci       Date:  2013-02-20       Impact factor: 4.677

Review 8.  Evidence-Based Recommendations for an Optimal Prenatal Supplement for Women in the U.S., Part Two: Minerals.

Authors:  James B B Adams; Jacob C C Sorenson; Elena L L Pollard; Jasmine K K Kirby; Tapan Audhya
Journal:  Nutrients       Date:  2021-05-28       Impact factor: 5.717

9.  Mood disorders and complementary and alternative medicine: a literature review.

Authors:  Naseem Akhtar Qureshi; Abdullah Mohammed Al-Bedah
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-14       Impact factor: 2.570

10.  Supplement of 5-hydroxytryptophan before induction suppresses inflammation and collagen-induced arthritis.

Authors:  Tao-Hsiang Yang; Peng-Yang Hsu; Menghsiao Meng; Che-Chun Su
Journal:  Arthritis Res Ther       Date:  2015-12-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.